Studies suggest that CMTM6 may modulate the activity of tumor-associated macrophages (TAMs), natural killer (NK) cells, and dendritic cells, thereby shaping the immune landscape of the tumor microenvironment. The gene discussed is CMTM6; the disease is neoplasm.